Tomasz D.
- Country
- Poland
- Department
- Urology
Research Overview
- Phase 3 Randomized Study of Perioperative Enfortumab Vedotin and Pembrolizumab Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
- Evaluation of Perioperative Pembrolizumab and Enfortumab Vedotin with Cystectomy Versus Cystectomy Alone in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
- Efficacy and Safety Evaluation of UGN-104 in Low-grade Upper Tract Urothelial Carcinoma: A Phase 3, Single-arm, Multicenter Study
Data & Insights
Has run more than one trial at 16 of 137 partner sites.
Specializations
Oncological Focus
This investigator specializes in treating muscle invasive bladder cancer, with particular emphasis on developing innovative therapeutic approaches for this challenging urological malignancy.
- Bladder Cancer Management
- Surgical Interventions
- Advanced Treatment Protocols
Their work involves examining various therapeutic combinations including immunotherapy and targeted treatments for bladder cancer patients.
Surgical Expertise
The investigator has extensive experience in radical cystectomy procedures and pelvic lymph node dissection, focusing on surgical outcomes in bladder cancer treatment.
- Perioperative Care
- Surgical Techniques
- Lymph Node Management
Their practice encompasses comprehensive surgical approaches for invasive bladder cancer treatment.
Treatment Innovation
The investigator explores combination therapy approaches using novel therapeutic agents such as immunotherapy and targeted treatments in bladder cancer care.
- Therapeutic Combinations
- Treatment Optimization
- Patient Outcomes
Their expertise includes evaluating treatment efficacy through survival metrics and patient response assessment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.